Last reviewed · How we verify

NCT03216018

Prevention Program Promoting Self Resilience, Positive Self-Image and Body Image Among Adolescents

Completed NA Last updated 12 September 2018
What this trial tests

NA trial testing Prevention program: "In Favor of Resilient Self" in Primary Prevention in 200 participants. Completed in 1 June 2018.

Timeline
1 June 2017
Primary endpoint
1 May 2018
1 June 2018

Quick facts

Lead sponsorTel Hai College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment200
Start date1 June 2017
Primary completion1 May 2018
Estimated completion1 June 2018
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Tel Hai College

Who can join

Adults 14 to 17, any sex, with Primary Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a group randomized controlled trial. High school classes were allocated by randomization to the intervention or control group by a Randomization function in Excel computer program. Outcomes were measured by questionnaire at pre-intervention, post-intervention and 3-months follow-up. The study protocol was approved by Tel Hai College institutional review board. Parents of all participants, in the intervention and in the control group, received information about the program and the study and were asked to provide informed consent.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility and effect of adding a concurrent parental component to a school-based wellness program using two modes of mobile-based technology - mixed methods evaluation of RCT.
    Golan M, Benifla S, Samo A, Alon N, et al · · 2022 · PMID 35164721 · DOI 10.1186/s12889-022-12581-7

Verify or expand the search:

Other recruiting trials for Primary Prevention

Currently open trials in the same condition.

Other Tel Hai College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03216018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing